Target Just Reported 13th Quarter Slump: 2 Turnaround Keys
Target just reported 13th quarter slump, prompting questions about management, costs, and the path to growth. Here ar...
When To Use Tactical Allocation With Index Funds Retirement
Discover timing cues for using tactical allocation with index funds retirement to potentially enhance returns without sacrificing core diversification.
23,450 articlesPizza Hut’s Owner Also Bets Big on Gyms and Caskets
Yum Brands agreed to divest Pizza Hut for about $2.7 billion, splitting the brand between LongRange Capital outside C...
This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
MSTR Playbook Shift Costs Investors as Bitcoin Sales Rise
MicroStrategy is monetizing BTC to back dividends and bolster liquidity, draining a portion of its planned sale capac...
Arthur Hayes Bought ETHFI; Upbit Listing Triggers Big Buzz
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
Prediction: TSMC Stock Going Higher After July 16 Outlook
As July 16 approaches, investors are weighing TSMC's Q2 results and what they mean for the stock. This article breaks...
Pitney Bowes (PBI) 2026 Q1 Earnings: Key Takeaways
Pitney Bowes is navigating a pivot from legacy mailing services to software, data, and commerce solutions. This break...
Unity 2026 Earnings Call: Key Takeaways and Outlook
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
Paul Tudor Jones Warns Trump-Era Boom Could Crash Markets
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
Celsius: From Highs, Stock - Is It a Buy Right Now?
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
$500? Dirt-Cheap Dividend Powerhouse Under $5 to Buy
As volatility eases, income-focused investors eye a dirt-cheap dividend powerhouse trading under $5. The article expl...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status